Zeffix 5 mg / ml Oral solution
- Licence status
- Active substances
- Lamivudine
- Dosage Form
- Oral solution
- Licence number
- EU/1/99/114/003
- Licence holder
- GlaxoSmithKline Trading Services Limited
Product documents
Licence information
- ATC code
- J05AF Nucleoside and nucleotide reverse transcriptase inhibitors, J05AF05 lamivudine
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Medicinal product subject to restricted medical prescription (See Annex I: Summary of Product Characteristics, section 4.2)
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 29/07/1999